|
2017
|
|
NEW
Interventions to increase tuberculosis case detection at primary healthcare or community-level services
Mhimbira FA, Cuevas LE, Dacombe R, Mkopi A, Sinclair D
|
|
|
|
UPDATE
Interventions for treating tuberculous pericarditis
Wiysonge C S, Ntsekhe M, Thabane L, Volmink J, Majombozi D, Gumedze F, Pandie S, Mayosi B M
|
|
|
|
UPDATE
Isoniazid for preventing tuberculosis in HIV-infected children
Zunza M, Gray DM, Young T, Cotton M, Zar HJ
|
|
|
|
UPDATE
Corticosteroids for tuberculous pleurisy
Ryan H, Yoo J, Darsini P
|
|
|
2016
|
|
NEW
Six-month therapy for abdominal tuberculosis
Jullien S, Jain S, Ryan H, Ahuja V
|
|
|
|
UPDATE
GenoType® MTBDRsl assay for resistance to second-line anti-tuberculosis drugs
Theron G, Peter J, Richardson M, Warren R, Dheda K, Steingart KR
|
|
|
|
NEW
Six months therapy for tuberculous meningitis
Jullien S, Ryan H, Modi M, Bhatia R
|
|
|
|
UPDATE
Nutritional supplements for people being treated for active tuberculosis
Grobler L, Nagpal S, Sudarsanam TD, Sinclair D
|
|
|
|
NEW
Fixed-dose combinations of drugs versus single-drug formulations for treating pulmonary tuberculosis
Gallardo CR, Rigau Comas D, Valderrama Rodríguez A, Roqué i Figuls M, Parker LA, Caylà J, Bonfill Cosp X
|
|
|
|
NEW
Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV-positive adults
Shah M, Hanrahan C, Wang ZY, Dendukuri N, Lawn SD, Denkinger CM, Steingart KR
|
|
|
|
UPDATE
Corticosteroids for managing tuberculous meningitis
Prasad K, Singh MB, Ryan H
|
|
|
2015
|
|
UPDATE
Incentives and enablers to improve adherence in tuberculosis
Lutge EE, Wiysonge CS, Knight SE, Sinclair D, Volmink J
|
|
|
|
UPDATE
Directly observed therapy for treating tuberculosis
Karumbi J, Garner P
|
|
|
2014
|
|
NEW
Adjunctive steroid therapy for managing pulmonary tuberculosis
Critchley JA, Orton LC, Pearson F
|
|
|
|
NEW
Reminder systems to improve patient adherence to tuberculosis clinic appointments for diagnosis and treatment
Liu Q, Abba K, Alejandria MM, Sinclair D, Balanag VM, Lansang MAD
|
|
|
|
NEW
The diagnostic accuracy of the GenoType® MTBDRsl assay for the detection of resistance to second-line anti-tuberculosis drugs
Theron G, Peter J, Richardson M, Barnard M, Donegan S, Warren R, Steingart KR, Dheda K
View current version (8 September 2016)
|
|
|
|
NEW
Antibiotic prophylaxis for preventing post solid organ transplant tuberculosis
Adamu B, Abdu A, Abba AA, Borodo MM, Tleyjeh IM
|
|
|
|
NEW
Intermittent versus daily therapy for treating tuberculosis in children
Bose A, Kalita S, ROse W, Tharyan P
|
|
|
|
UPDATE
Xpert ® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults
Steingart KR, Schiller I, Home Dj, Pai M, Boehme CC, Dendukuri N
|
|
|
2013
|
|
NEW
Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB
Sharma SK, Sharma A, Kadhiravan T, Tharyan P
|
|
|
|
UPDATE
Fluoroquinolones for treating tuberculosis (presumed drug-sensitive)
Ziganshina LE, Titarenko AF, Davies GR
|
|
|
|
NEW
Treating BCG-induced disease in children
Cuello-García CA, Pérez-Gaxiola G, Jiménez Gutiérrez C
|
|
|
2012
|
|
NEW
Patient education and counselling for promoting adherence to treatment for tuberculosis
M'Imunya JM, Kredo T, Volmink J
|
|
|
|
NEW
Material incentives and enablers in the management of tuberculosis
Lutge EE, Wiysonge CS, Knight SE, Volmink J
|
|
|
2011
|
|
UPDATE
Nutritional supplements for people being treated for active tuberculosis
Sinclair D, Abba k, Grobler L, Sudarsanam TD
|
|
|
|
NEW
Active case finding in contacts of people with tuberculosis
Fox GJ, Dobler CC, Marks GB
|
|
